Anebulo Pharmaceuticals Files 10-Q for Q3 2025

Ticker: ANEB · Form: 10-Q · Filed: May 13, 2025 · CIK: 1815974

Anebulo Pharmaceuticals, Inc. 10-Q Filing Summary
FieldDetail
CompanyAnebulo Pharmaceuticals, Inc. (ANEB)
Form Type10-Q
Filed DateMay 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

Anebulo Pharma (ANEB) filed its Q3 2025 10-Q. Financials updated.

AI Summary

Anebulo Pharmaceuticals, Inc. filed a 10-Q for the period ending March 31, 2025. The company, operating in pharmaceutical preparations, reported its financial status. Key financial data points from previous periods are available, including common stock, additional paid-in capital, and retained earnings as of June 30, 2023, September 30, 2023, December 31, 2023, and June 30, 2024.

Why It Matters

This filing provides investors with an update on Anebulo Pharmaceuticals' financial health and operational status for the third quarter of fiscal year 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Anebulo faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • Q3 2025 — Reporting Period (The 10-Q covers the third quarter of fiscal year 2025.)
  • 0630 — Fiscal Year End (Indicates the company's fiscal year concludes on June 30th annually.)

Key Players & Entities

  • Anebulo Pharmaceuticals, Inc. (company) — Filer of the 10-Q
  • 0001815974 (company) — Central Index Key for Anebulo Pharmaceuticals, Inc.
  • 2834 (industry) — Standard Industrial Classification for Pharmaceutical Preparations
  • 0630 (date) — Fiscal year end
  • 20250331 (date) — Conformed period of report

FAQ

What is the reporting period for this 10-Q filing?

The conformed period of report is March 31, 2025.

What is Anebulo Pharmaceuticals, Inc.'s Central Index Key?

Anebulo Pharmaceuticals, Inc.'s Central Index Key is 0001815974.

What is the Standard Industrial Classification for Anebulo Pharmaceuticals, Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

When is Anebulo Pharmaceuticals, Inc.'s fiscal year end?

The company's fiscal year ends on June 30.

What is the filing date of this 10-Q?

This 10-Q was filed on May 13, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Anebulo Pharmaceuticals, Inc. (ANEB).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.